Table 1.
Characteristics of study participants by country and treatment group
| Austria | Italy | Norway | Spain | Sweden | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | I | p-value | C | I | p-value | C | I | p-value | C | I | p-value | C | I | p-value | |
| Number of patients | 308 | 277 | 171 | 164 | 165 | 170 | 128 | 153 | 128 | 70 | |||||
| Number of centres | 60 | 68 | 19 | 18 | 17 | 18 | 16 | 24 | 3 | 3 | |||||
| Age, years | 55.5 | 57.8 | 0.07 | 50.8 | 52.9 | 0.19 | 47.5 | 50.1 | 0.12 | 51.0 | 50.2 | 0.64 | 56.4 | 61.9 | 0.009 |
| (15.6) | (14.9) | (14.4) | (14.2) | (14.7) | (15.3) | (13.6) | (15.0) | (14.0) | (14.6) | ||||||
| Sex, male | 164 | 136 | 0.32 | 71 | 73 | 0.58 | 90 | 86 | 0.47 | 46 | 69 | 0.12 | 56 | 22 | 0.09 |
| (53.3) | (49.1) | (41.5) | (44.5) | (54.6) | (50.6) | (35.9) | (45.1) | (43.8) | (31.4) | ||||||
| Current smokers | 117 | 104 | 0.91 | 36 | 32 | 0.73 | 37 | 46 | 0.33 | 27 | 42 | 0.22 | 18 | 9 | 0.81 |
| (38.0) | (37.6) | (21.1) | (19.5) | (22.4) | (27.1) | (21.1) | (27.5) | (14.1) | (12.9) | ||||||
| Current drinkers | 57 | 38 | 0.12 | 60 | 62 | 0.61 | 121 | 120 | 0.58 | 4 | 10 | 0.19 | 101 | 46 | 0.04 |
| (18.5) | (13.7) | (35.1) | (37.8) | (73.3) | (70.6) | (3.1) | (6.5) | (78.9) | (65.7) | ||||||
| Diagnosis in 2009* | 18 | 25 | 0.04 | 64 | 66 | 0.60 | 108 | 55 | 0.05 | 85 | 95 | 0.45 | 2 | 2 | 0.11 |
| (11.3) | (20.3) | (37.4) | (40.2) | (85.7) | (74.3) | (66.4) | (62.1) | (4.9) | (20.0) | ||||||
Values are number of patients (%), except for age [mean (SD)]. C, control (usual care); I, Implementation (structured treatment pathway).
*
Date of diagnosis was available in the following number of patients: Austria: 159 Control, 123 Implementation; Italy: 171 Control, 164 Implementation; Norway: 126 Control, 74 Implementation; Spain: 128 Control, 153 Implementation; Sweden: 41 Control, 10 Implementation.